Direkt zum Inhalt
Merck

Aromatic L-amino acid decarboxylase deficiency: diagnostic methodology.

Clinical chemistry (1992-12-01)
K Hyland, P T Clayton
ZUSAMMENFASSUNG

Aromatic L-amino acid decarboxylase (EC. 4.1.1.28) deficiency is a newly described inborn error of metabolism that affects serotonin and dopamine biosynthesis. The major biochemical markers for this disease are increases of L-dopa, 3-methoxytyrosine, and 5-hydroxytryptophan in urine, plasma, and cerebrospinal fluid together with decreased cerebrospinal fluid concentrations of homovanillic acid and 5-hydroxyindoleacetic acid. In addition, concentrations of vanillactic acid are increased in the urine. Specific HPLC and gas chromatography-mass spectrometry methods are described that permit the identification and measurement of these metabolites in the above body fluids. Simplified assays for human plasma L-dopa decarboxylase and liver L-dopa and 5-hydroxytryptophan decarboxylase, used to demonstrate the enzyme deficiency, are also reported.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
3,4-Dihydroxy-L-Phenylalanin, ≥98% (TLC)
Preise und Verfügbarkeit sind derzeit nicht verfügbar.
Supelco
Levodopa, Pharmaceutical Secondary Standard; Certified Reference Material
Preise und Verfügbarkeit sind derzeit nicht verfügbar.
Sigma-Aldrich
Homovanillesäure, Fluorimetric reagent
Preise und Verfügbarkeit sind derzeit nicht verfügbar.
Supelco
N-Acetyl-L-Tyrosin, Pharmaceutical Secondary Standard; Certified Reference Material
Preise und Verfügbarkeit sind derzeit nicht verfügbar.